BioAtla, Inc. (BCAB) Q4 2024 Earnings Call Transcript

2025-03-27 18:18:03 ET

BioAtla, Inc. (BCAB)

Q4 2024 Earnings Conference Call

March 27, 2025 4:30 p.m. ET

Company Participants

Bruce Mackle - LifeSci Advisors, Investor Relations

Jay Short - Chairman, Chief Executive Officer and Cofounder

Richard Waldron - Chief Financial Officer

Eric Sievers - Chief Medical Officer

Sheri Lydick - Chief Commercial Officer

Conference Call Participants

Jeet Mukherjee - BTIG

Tony Butler - Rodman & Renshaw

Arthur He - H.C. Wainwright

Presentation

Operator

Good day, everyone, and welcome to today's BioAtla Fourth Quarter and Fiscal Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. Later we will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions]

It is now my pleasure to turn the conference over to Mr. Bruce Mackle of LifeSci Advisors. Please go ahead, sir.

Bruce Mackle

Thank you, Operator, and good afternoon, everyone. With me today on the phone from BioAtla are Dr. Jay Short, Chairman, CEO, and Cofounder; and Richard Waldron, Chief Financial Officer. Following today's call, Dr. Eric Sievers, Chief Medical Officer; and Sheri Lydick, Chief Commercial Officer, will join Jay and Rick in a short Q&A.

Earlier this afternoon, BioAtla released financial results and a business update for the fourth quarter and full-year ended December 31, 2024. A copy of the press release and corporate presentation are available on the company's website....

Read the full article on Seeking Alpha

For further details see: